Adjuvant Chemotherapy for Stage II Colon Cancer: Insight from a SEER-Medicare Cohort ASCO 2001 Abstract 488 Conclusions: We found that in real world practice a substantial minority of stage II colon cancer patients receives adjuvant chemotherapy; but there appears to be no evidence that the treated patients realize survival benefit. http://www.asco.org/asco/ascoMainConstructor/1,1003,_12-002324-00_29-00A-00_18-002001-00_19-00488,00.asp